BEGONIA MEDICAL LTD Company accounts

COMPANY REGISTRATION NUMBER: 08546945

BEGONIA MEDICAL LTD

Unaudited Financial Statements

31 March 2025

BEGONIA MEDICAL LTD

Financial Statements

Year ended 31 March 2025

Contents	Page

Directors' report	1

Statement of income and retained earnings	2

Statement of financial position	3

Notes to the financial statements	5

BEGONIA MEDICAL LTD

Directors' Report

Year ended 31 March 2025

The directors present their report and the unaudited financial statements of the company for the year ended 31 March 2025 .

Directors

The directors who served the company during the year were as follows:

S R Kumbhare
Dr R K Sreenivasan

Small company provisions

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

This report was approved by the board of directors on 3 December 2025 and signed on behalf of the board by:

Dr R K Sreenivasan

Director

Registered office:

c/o The Accounting Centre Limited

First Floor, 736 High Road

North Finchley

London

N12 9QD

BEGONIA MEDICAL LTD

Statement of Income and Retained Earnings

Year ended 31 March 2025

	2025	2024
Note	£	£
Turnover	96,024	86,742

	--------	--------
Gross profit	96,024	86,742

Administrative expenses	33,537	28,618
	--------	--------
Operating profit	62,487	58,124

Income from listed investments		2,134	781
Other interest receivable and similar income		( 3,370)	3,491
		--------	--------
Profit before taxation	5	61,251	62,396

Tax on profit	16,312	13,943
	--------	--------
Profit for the financial year and total comprehensive income	44,939	48,453
	--------	--------

Dividends paid and payable	6	( 12,000)	( 4,000)

Retained earnings at the start of the year	163,795	119,342
	---------	---------
Retained earnings at the end of the year	196,734	163,795
	---------	---------

All the activities of the company are from continuing operations.

BEGONIA MEDICAL LTD

Statement of Financial Position

31 March 2025

	2025	2024
Note	£	£

Fixed assets

Tangible assets	7	17,030	29,803
Investments	8	138,072	74,827
		---------	---------
		155,102	104,630

Current assets

Debtors	9	7,648	8,130
Cash at bank and in hand		55,029	66,398
		--------	--------
		62,677	74,528

Creditors: amounts falling due within one year	10	20,945	15,263
		--------	--------
Net current assets		41,732	59,265
		---------	---------
Total assets less current liabilities		196,834	163,895
		---------	---------
Net assets		196,834	163,895
		---------	---------

Capital and reserves

Called up share capital		100	100
Profit and loss account	11	196,734	163,795
		---------	---------
Shareholders funds		196,834	163,895
		---------	---------

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

BEGONIA MEDICAL LTD

Statement of Financial Position (continued)

31 March 2025

These financial statements were approved by the board of directors and authorised for issue on 3 December 2025 , and are signed on behalf of the board by:

S R Kumbhare	Dr R K Sreenivasan
Director	Director

Company registration number: 08546945

BEGONIA MEDICAL LTD

Notes to the Financial Statements

Year ended 31 March 2025

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is c/o The Accounting Centre Limited, First Floor, 736 High Road, North Finchley, London, N12 9QD.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services rendered, stated net of discounts. Revenue from the rendering of services is recognised when the significant risks and rewards of ownership of the services have transferred to the buyer, usually after rendering of the services, the amount of revenue can be measured reliably, it is probable that the associated economic benefits will flow to the entity, and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Income tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Fixtures and fittings	-	25% straight line
Motor vehicles	-	25% straight line

Investments

Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.

Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

Financial instruments

A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 3 (2024: 2 ).

5. Profit before taxation

Profit before taxation is stated after charging/crediting:

	2025	2024
	£	£
Depreciation of tangible assets	12,773	12,773
Fair value adjustments to financial assets measured at fair value through profit or loss	3,432	( 3,273)
	--------	--------

6. Dividends

	2025	2024
	£	£
Dividends paid during the year (excluding those for which a liability existed at the end of the prior year )	12,000	4,000
	--------	-------

7. Tangible assets

	Fixtures and fittings	Motor vehicles	Total
	£	£	£
Cost
At 1 April 2024 and 31 March 2025	1,742	51,090	52,832
	-------	--------	--------
Depreciation
At 1 April 2024	1,741	21,288	23,029
Charge for the year	–	12,773	12,773
	-------	--------	--------
At 31 March 2025	1,741	34,061	35,802
	-------	--------	--------
Carrying amount
At 31 March 2025	1	17,029	17,030
	-------	--------	--------
At 31 March 2024	1	29,802	29,803
	-------	--------	--------

8. Investments

	Listed Investments
	£
Cost
At 1 April 2024	74,827
Additions	66,677
	---------
At 31 March 2025	141,504
	---------
Impairment
At 1 April 2024	–
Impairment losses	3,432
	---------
At 31 March 2025	3,432
	---------

Carrying amount
At 31 March 2025	138,072
	---------
At 31 March 2024	74,827
	---------

9. Debtors

	2025	2024
	£	£
Trade debtors	7,648	6,139
Other debtors	–	1,991
	-------	-------
	7,648	8,130
	-------	-------

10. Creditors: amounts falling due within one year

	2025	2024
	£	£
Accruals and deferred income	2,640	1,320
Corporation tax	16,298	13,943
Director loan accounts	2,007	–
	--------	--------
	20,945	15,263
	--------	--------

11. Reserves

Profit and loss account - This reserve records retained earnings and accumulated losses.

12. Directors' advances, credits and guarantees

This has been shown within note "Creditors: amounts falling due within one year".

13. Controlling party

The company was under the control of its directors throughout the current year.